Discovery of Novel Isatin-Based p53 Inducers

P. Davidovich, V. Aksenova, V. Petrova, D. Tentler, D. Orlova, S. Smirnov, V. Gurzhiy, A. L. Okorokov, A. Garabadzhiu, G. Melino, N. Barlev, V. Tribulovich

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

A series of isatin Schiff base derivatives were identified during in silico screening of the small molecule library for novel activators of p53. The compounds selected based on molecular docking results were further validated by a high-content screening assay using U2OS human osteosarcoma cells with an integrated EGFP-expressing p53-dependent reporter. The hit compounds activated and stabilized p53, as shown by Western blotting, at higher rates than the well-known positive control Nutlin-3. Thus, the p53-activating compounds identified by this approach represent useful molecular probes for various cancer studies.

Original languageEnglish
Pages (from-to)856-860
Number of pages5
JournalACS Medicinal Chemistry Letters
Volume6
Issue number8
DOIs
Publication statusPublished - Aug 13 2015

Fingerprint

Isatin
Small Molecule Libraries
Molecular Probes
Schiff Bases
Osteosarcoma
Computer Simulation
Screening
Western Blotting
Assays
Neoplasms
Derivatives
Molecules
nutlin 3

Keywords

  • in silico
  • in vivo assay
  • isatin Mannich and Schiff bases
  • MDM2
  • p53 activators
  • protein-protein interactions

ASJC Scopus subject areas

  • Organic Chemistry
  • Drug Discovery
  • Biochemistry

Cite this

Davidovich, P., Aksenova, V., Petrova, V., Tentler, D., Orlova, D., Smirnov, S., ... Tribulovich, V. (2015). Discovery of Novel Isatin-Based p53 Inducers. ACS Medicinal Chemistry Letters, 6(8), 856-860. https://doi.org/10.1021/acsmedchemlett.5b00011

Discovery of Novel Isatin-Based p53 Inducers. / Davidovich, P.; Aksenova, V.; Petrova, V.; Tentler, D.; Orlova, D.; Smirnov, S.; Gurzhiy, V.; Okorokov, A. L.; Garabadzhiu, A.; Melino, G.; Barlev, N.; Tribulovich, V.

In: ACS Medicinal Chemistry Letters, Vol. 6, No. 8, 13.08.2015, p. 856-860.

Research output: Contribution to journalArticle

Davidovich, P, Aksenova, V, Petrova, V, Tentler, D, Orlova, D, Smirnov, S, Gurzhiy, V, Okorokov, AL, Garabadzhiu, A, Melino, G, Barlev, N & Tribulovich, V 2015, 'Discovery of Novel Isatin-Based p53 Inducers', ACS Medicinal Chemistry Letters, vol. 6, no. 8, pp. 856-860. https://doi.org/10.1021/acsmedchemlett.5b00011
Davidovich P, Aksenova V, Petrova V, Tentler D, Orlova D, Smirnov S et al. Discovery of Novel Isatin-Based p53 Inducers. ACS Medicinal Chemistry Letters. 2015 Aug 13;6(8):856-860. https://doi.org/10.1021/acsmedchemlett.5b00011
Davidovich, P. ; Aksenova, V. ; Petrova, V. ; Tentler, D. ; Orlova, D. ; Smirnov, S. ; Gurzhiy, V. ; Okorokov, A. L. ; Garabadzhiu, A. ; Melino, G. ; Barlev, N. ; Tribulovich, V. / Discovery of Novel Isatin-Based p53 Inducers. In: ACS Medicinal Chemistry Letters. 2015 ; Vol. 6, No. 8. pp. 856-860.
@article{1407c9e42e2b4d0db035c6c6e2a71656,
title = "Discovery of Novel Isatin-Based p53 Inducers",
abstract = "A series of isatin Schiff base derivatives were identified during in silico screening of the small molecule library for novel activators of p53. The compounds selected based on molecular docking results were further validated by a high-content screening assay using U2OS human osteosarcoma cells with an integrated EGFP-expressing p53-dependent reporter. The hit compounds activated and stabilized p53, as shown by Western blotting, at higher rates than the well-known positive control Nutlin-3. Thus, the p53-activating compounds identified by this approach represent useful molecular probes for various cancer studies.",
keywords = "in silico, in vivo assay, isatin Mannich and Schiff bases, MDM2, p53 activators, protein-protein interactions",
author = "P. Davidovich and V. Aksenova and V. Petrova and D. Tentler and D. Orlova and S. Smirnov and V. Gurzhiy and Okorokov, {A. L.} and A. Garabadzhiu and G. Melino and N. Barlev and V. Tribulovich",
year = "2015",
month = "8",
day = "13",
doi = "10.1021/acsmedchemlett.5b00011",
language = "English",
volume = "6",
pages = "856--860",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "8",

}

TY - JOUR

T1 - Discovery of Novel Isatin-Based p53 Inducers

AU - Davidovich, P.

AU - Aksenova, V.

AU - Petrova, V.

AU - Tentler, D.

AU - Orlova, D.

AU - Smirnov, S.

AU - Gurzhiy, V.

AU - Okorokov, A. L.

AU - Garabadzhiu, A.

AU - Melino, G.

AU - Barlev, N.

AU - Tribulovich, V.

PY - 2015/8/13

Y1 - 2015/8/13

N2 - A series of isatin Schiff base derivatives were identified during in silico screening of the small molecule library for novel activators of p53. The compounds selected based on molecular docking results were further validated by a high-content screening assay using U2OS human osteosarcoma cells with an integrated EGFP-expressing p53-dependent reporter. The hit compounds activated and stabilized p53, as shown by Western blotting, at higher rates than the well-known positive control Nutlin-3. Thus, the p53-activating compounds identified by this approach represent useful molecular probes for various cancer studies.

AB - A series of isatin Schiff base derivatives were identified during in silico screening of the small molecule library for novel activators of p53. The compounds selected based on molecular docking results were further validated by a high-content screening assay using U2OS human osteosarcoma cells with an integrated EGFP-expressing p53-dependent reporter. The hit compounds activated and stabilized p53, as shown by Western blotting, at higher rates than the well-known positive control Nutlin-3. Thus, the p53-activating compounds identified by this approach represent useful molecular probes for various cancer studies.

KW - in silico

KW - in vivo assay

KW - isatin Mannich and Schiff bases

KW - MDM2

KW - p53 activators

KW - protein-protein interactions

UR - http://www.scopus.com/inward/record.url?scp=84938917201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938917201&partnerID=8YFLogxK

U2 - 10.1021/acsmedchemlett.5b00011

DO - 10.1021/acsmedchemlett.5b00011

M3 - Article

VL - 6

SP - 856

EP - 860

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 8

ER -